ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOWA COMPANY, LTD.
  3. Financials
  4. Cost of revenue

KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
SummaryFinancialsDividendsHistoryWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 2023160,789+48.36%
Mar 31, 2022108,375-7.48%
Mar 31, 2021117,134-2.14%
Mar 31, 2020119,701-5.11%
Mar 31, 2019126,150+5.14%
Mar 31, 2018119,979+9.93%
Mar 31, 2017109,146-2.45%
Mar 31, 2016111,892-15.10%
Mar 31, 2015131,797-1.11%
Mar 31, 2014133,276-20.28%
Mar 31, 2013167,175

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat